?? We're moving! Stay updated on Applied BioMath’s innovative #ComputationalModeling and #QuantitativeSystemsPharmacology advancements over at Certara, including: ?? Expert insights on predictive modeling and its impact on drug discovery and development ?? Announcements of our upcoming webinars and workshops ?? Where to find us at industry events Hit that "Follow" button now to make sure you don't miss out! >> Certara ??? #AppliedBioMath #QSP #Pharma #Biotech #DrugDiscovery #ModelingAndSimulation #StayUpdated #JoinUs
Applied BioMath
生物技术研究
Concord，Massachusetts 5,285 位关注者
Model-Informed Drug Discovery and Development (MID3) services, software, and R&D company.
关于我们
Founded in 2013, Applied BioMath uses mathematical modeling and simulation to provide quantitative and predictive guidance to biotechnology and pharmaceutical companies to help accelerate and de-risk drug research and development. Our Model-Aided Drug Invention (MADI) approach employs proprietary algorithms and software to support groups worldwide in decision-making from early research through clinical trials. The Applied BioMath team leverages their decades of expertise in biology, mathematical modeling and analysis, high-performance computing, and industry experience to help groups better understand their candidate, its best-in-class parameters, competitive advantages, patients, and the best path forward into and in the clinic. For more information about Applied BioMath and its services, visit www.appliedbiomath.com.
- 网站
-
https://www.appliedbiomath.com
Applied BioMath的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Concord，Massachusetts
- 类型
- 私人持股
- 创立
- 2013
- 领域
- Mechanistic PK/PD、Quantitative Decision Making、Risk Assessments、Predict optimal drug properties for lead gen or clinical candidate selection、Phase 1 and Phase 2 support and analysis和Technical Due Dilligence
地点
Applied BioMath员工
动态
-
?? We're moving! Stay updated on Applied BioMath’s innovative #ComputationalModeling and #QuantitativeSystemsPharmacology advancements over at Certara, including: ?? Expert insights on predictive modeling and its impact on drug discovery and development ?? Announcements of our upcoming webinars and workshops ?? Where to find us at industry events Hit that "Follow" button now to make sure you don't miss out! >> Certara ??? #AppliedBioMath #QSP #Pharma #Biotech #DrugDiscovery #ModelingAndSimulation #StayUpdated #JoinUs
-
-
?? We're moving! Keep updated on Applied BioMath’s innovative #ComputationalModeling and #QuantitativeSystemsPharmacology advancements over at Certara, including: ?? Expert insights on predictive modeling and its impact on drug discovery and development ?? Announcements of our upcoming webinars and workshops ?? Where to find us at industry events Hit that "Follow" button now to make sure you don't miss out! >> Certara ??? #AppliedBioMath #QSP #Pharma #Biotech #DrugDiscovery #ModelingAndSimulation #StayUpdated #JoinUs
-
-
Boost your targeted radiation therapy (TRT) development with interactive learning. Our upcoming webinar on clinical pharmacology and model-informed drug development for TRTs offers more than just presentations. Engage with our expert speakers during a live Q&A session and get your critical questions answered. Register today: https://ow.ly/TwXh50S0a7n #ClinicalPharmacology #DrugDevelopment #Oncology #TargetedRadiationTherapy #MIDD #RegulatoryCompliance #DosingStrategies #InSilicoPrediction #VirtualTrialDesign?
-
-
View our case study to learn how Applied BioMath Assess? can be used to evaluate the risk of on-target, off-tumor toxicities for CD3 bispecific T-cell engagers and to make an early prediction about therapeutic index and projections of effective and tolerable doses for T-cell engagers in solid tumors. Learn more at: https://lnkd.in/ePquuEfw #TCEs #tcellengagers #preclinicaldevelopent #clinicladevelopment #solidtumors
-
Learn how we developed a mathematical model to compare dose prediction for two checkpoint inhibitors, atezolizumab and magrolimab, in our newest publication, "Comparison of dose selection based on target engagement versus inhibition of receptor–ligand interaction for checkpoint inhibitors." View the publication at: https://lnkd.in/eaAEAGJB
-
Associate Director | Drug Discovery & Development | Biologics | Gene Therapies | Business | Strategy | ex-Janssen | ex-Moderna | ex-Applied BioMath
We are at #ISCT 2024. (International Society for Cell & Gene Therapy) Vancouver, May 28-Jun 1 If you are attending, let's chat about the impact of modeling in de-risking and accelerating your #drug #development pipeline. Certara Applied BioMath #celltherapy #genetherapy #preclinical #clinical #modeling
-
-
We're at the 6th Annual Cell Engager Summit in Boston! Interested in speaking to one of our team members? Reach out to?Katie Williams, PhD, and?Caroline Mello to discuss your project needs!?
-
-
Learn how QSP models can assist in accelerating the reuse of immuno-oncology drugs, such as T-cell engagers and CAR-T therapies, in the autoimmune space in our latest blog written by?Saheli Sarkar, PhD, Senior Principal Scientist, and?Marc Presler, PhD, Associate Director of Biology at Applied BioMath. Read the blog at: https://lnkd.in/eT8TtQgF #immunooncology?#autoimmunediseases?#qsp?#mathematicalmodeling
-
-
Are you attending the 6th Annual Cell Engager Summit next week??Join us on Wednesday, May 22nd, as Fei Hua, Vice President of Modeling & Simulation Services at Applied BioMath, discusses the value of QSP modeling in her presentation?highlighting TCEs.?Learn more about our presence at this conference at:?https://lnkd.in/eDuzV8B8 and reach out to Katie Williams?and Caroline Mello?to connect on-site!
-